Peter Reichardt

Dr. Peter Reichardt is a leading European GIST specialist who has been central to developing ESMO guidelines for GIST management and has been an investigator in major GIST clinical trials. He has contributed research on optimal imatinib dosing strategies, secondary resistance mechanisms, and sequential targeted therapy approaches in advanced GIST. His work has shaped European practice in sarcoma and GIST management.